India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Aarti Pharmalabs Ltd.

Income Statement - Standalone

Market Cap.(`)	7903.79 Cr.	P/BV	4.26	Book Value (`)	204.86
52 Week High/Low ( ` )	884/497	FV/ML	5/1	P/E(X)	29.02
Book Closure	14/02/2025	EPS (`)	30.06	Div Yield (%)	0.00

(` in Crs.)

You can view the Standalone Income Statement for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	5.00	5.00	5.00	10.00	10.00


INCOME
Revenue From Operations [Net]	1771.35	1468.03	1503.36	934.66	0.00
Other Operating Revenues	0.00	34.10	7.89	6.36	0.00
Total Operating Revenues	1771.35	1502.13	1511.25	941.02	0.00

Other Income	14.49	11.01	1.28	2.51	0.00
Total Revenue	1785.84	1513.14	1512.53	943.53	0.00

EXPENSES
Cost Of Materials Consumed	803.98	761.57	899.45	550.19	0.00
Purchase Of Stock-In Trade	27.43	13.76	9.70	0.46	0.00
Operating And Direct Expenses	0.00	0.00	223.78	141.68	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	47.85	-23.36	-91.22	-32.54	0.00
Employee Benefit Expenses	152.88	130.33	122.16	79.98	0.00
Finance Costs	25.63	16.63	20.49	11.34	0.00
Depreciation And Amortisation Expenses	79.06	66.01	55.77	37.23	0.00
Other Expenses	312.66	273.67	39.05	21.47	0.00
Total Expenses	1449.50	1238.62	1279.17	809.81	0.00

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	336.34	274.52	233.36	133.73	0.00

Profit/Loss Before Tax	336.34	274.52	233.36	133.73	0.00

Tax Expenses-Continued Operations
Current Tax	78.99	49.12	52.13	22.50	0.00
Deferred Tax	0.00	27.82	9.50	4.50	0.00
Tax For Earlier Years	0.00	-3.06	0.00	0.00	0.00
Total Tax Expenses	78.99	73.87	61.63	27.00	0.00
Profit/Loss After Tax And Before ExtraOrdinary Items	257.35	200.65	171.73	106.73	0.00

Profit/Loss From Continuing Operations	257.35	200.65	171.73	106.73	0.00

Profit/Loss For The Period	257.35	200.65	171.73	106.73	0.00

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	28.39	22.14	18.95	11.78	-0.18
Diluted EPS (Rs.)	28.38	22.14	18.95	11.78	-0.18

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	18.13	18.13	0.00	0.00
Equity Dividend Rate (%)	100.00	60.00	40.00	0.00	0.00

Aarti Pharmalabs Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	7903.79 Cr.	P/BV	4.26	Book Value (`)	204.86
52 Week High/Low ( ` )	884/497	FV/ML	5/1	P/E(X)	29.02
Book Closure	14/02/2025	EPS (`)	30.06	Div Yield (%)	0.00

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR
FaceValue	5.00	5.00	5.00	10.00
No. of Equity Shares (in Lacs)	906.35	906.26	906.26	908.76

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	45.32	45.31	45.31	45.56
Total Share Capital	45.32	45.31	45.31	45.56

Reserves and Surplus	1944.59	1711.73	1513.17	1340.92
Total Reserves and Surplus	1944.59	1711.73	1513.17	1340.92
Total Shareholders Funds	1989.91	1757.04	1558.49	1386.48

NON-CURRENT LIABILITIES
Long Term Borrowings	103.56	0.04	0.18	0.55
Deferred Tax Liabilities [Net]	128.40	107.92	78.84	70.67
Other Long Term Liabilities	19.37	16.66	0.53	1.53
Long Term Provisions	8.12	6.06	1.32	0.00
Total Non-Current Liabilities	259.45	130.68	80.87	72.76

CURRENT LIABILITIES
Short Term Borrowings	292.80	264.06	213.78	337.73
Trade Payables	277.83	378.32	346.76	214.59
Other Current Liabilities	74.68	45.69	19.81	19.39
Short Term Provisions	11.74	6.31	11.21	8.96
Total Current Liabilities	657.05	694.39	591.57	580.66

Total Capital And Liabilities	2906.41	2582.11	2230.93	2039.90

ASSETS
NON-CURRENT ASSETS
Tangible Assets	1171.89	1014.69	923.87	780.09
Intangible Assets	30.67	16.85	0.18	0.23
Capital Work-In-Progress	306.58	78.50	62.20	165.23
Intangible Assets Under Development	0.00	58.42	39.67	22.14
Fixed Assets	1509.14	1168.46	1025.93	967.68
Goodwill On Consolidation	1.78	1.78	1.78	1.78
Non-Current Investments	29.24	36.78	35.52	32.23
Long Term Loans And Advances	7.30	5.85	0.00	0.00
Other Non-Current Assets	36.77	23.59	11.93	10.07
Total Non-Current Assets	1584.24	1236.46	1075.17	1011.75


CURRENT ASSETS
Current Investments	47.56	70.39	38.18	0.00
Inventories	587.58	642.86	602.04	475.45
Trade Receivables	575.40	519.34	440.05	376.66
Cash And Cash Equivalents	8.65	24.07	25.00	83.27
Short Term Loans And Advances	1.01	1.25	7.10	6.14
OtherCurrentAssets	101.96	87.73	43.38	86.63
Total Current Assets	1322.17	1345.64	1155.76	1028.15

Total Assets	2906.41	2582.11	2230.93	2039.90

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	36.16	20.86	397.48

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00	36.78	35.52	32.23

CURRENT INVESTMENTS
Current Investments Unquoted Book Value	0.00	0.00	38.18	0.00

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Aarti Pharmalabs Ltd.

Income Statement - Standalone

Aarti Pharmalabs Ltd.

Balance Sheet - Consolidated